⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 1, 2026International Journal of UrologyOpen Access

Editorial Comment on Beyond Total PSA : Clinical Significance of S2 , 3PSA % in Reducing Unnecessary Prostate Biopsies

View Full Paper

Ask AI

Bookmark

Share

Key Points

The commentary assesses the clinical importance of S2 and 3PSA percentages in prostate biopsy decision-making.
Review of current PSA metrics
Analysis of biopsy outcomes
Discussion of clinical implications
S2 and 3PSA metrics may help reduce unnecessary biopsies
Improved patient selection for biopsies is suggested
Enhancing diagnostic accuracy in prostate cancer detection is emphasized.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Editorial comment explores the role of S2 and 3PSA metrics in minimizing unnecessary prostate biopsies, implying improved patient care.

Abstract

The author declares no conflicts of interest.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yusuke Goto (2026) studied this question.

synapsesocial.com/papers/69ba424e4e9516ffd37a26ba https://doi.org/10.1111/iju.70401

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Editorial Comment Regarding “Shifts in Diagnostic Approaches for Prostate Cancer: Impact of <scp>MRI</scp>‐Informed Biopsies on Low‐Risk Cancer Detection”2025
2Beyond Total <scp>PSA</scp> : Clinical Significance of <scp>S2</scp> , <scp>3PSA</scp> % in Reducing Unnecessary Prostate BiopsiesReview · 2026 · 5 citations
3Avoiding unnecessary biopsy in suspicious prostate cancer using PRIMARY score ≤3 and PSAD ≤0.2 ng/mL/cm3: a real-world, dual-center study from ChinaOriginal Research · 2026 · 3 citations
4MP49-08 USEFULNESS OF FREE PSA RATIO TO ENHANCE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN PATIENTS WITH PIRADS <3 AND PSA ≤102024
5Real‐World Clinical Evaluation of S2,3PSA Test in a Prostate Biopsy Cohort With PSA Level of 4–10 ng/mLOriginal Research · 2026